Niels Juul

Ephedrine versus Phenylephrine Effect on Cerebral Blood Flow and Oxygen Consumption in Anesthetized Brain Tumor Patients: A Randomized Clinical Trial

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Background: Studies in anesthetized patients suggest that phenylephrine reduces regional cerebral oxygen saturation compared with ephedrine. The present study aimed to quantify the effects of phenylephrine and ephedrine on cerebral blood flow and cerebral metabolic rate of oxygen in brain tumor patients. The authors hypothesized that phenylephrine reduces cerebral metabolic rate of oxygen in selected brain regions compared with ephedrine. Methods: In this double-blinded, randomized clinical trial, 24 anesthetized patients with brain tumors were randomly assigned to ephedrine or phenylephrine treatment. Positron emission tomography measurements of cerebral blood flow and cerebral metabolic rate of oxygen in peritumoral and normal contralateral regions were performed before and during vasopressor infusion. The primary endpoint was between-group difference in cerebral metabolic rate of oxygen. Secondary endpoints included changes in cerebral blood flow, oxygen extraction fraction, and regional cerebral oxygen saturation. Results: Peritumoral mean ± SD cerebral metabolic rate of oxygen values before and after vasopressor (ephedrine, 67.0 ± 11.3 and 67.8 ± 25.7 µmol · 100 g -1· min -1; phenylephrine, 68.2 ± 15.2 and 67.6 ± 18.0 µmol · 100 g -1· min -1) showed no intergroup difference (difference [95% CI], 1.5 [-13.3 to 16.3] µmol · 100 g -1· min -1[P = 0.839]). Corresponding contralateral hemisphere cerebral metabolic rate of oxygen values (ephedrine, 90.8 ± 15.9 and 94.6 ± 16.9 µmol · 100 g -1· min -1; phenylephrine, 100.8 ± 20.7 and 96.4 ± 17.7 µmol · 100 g -1· min -1) showed no intergroup difference (difference [95% CI], 8.2 [-2.0 to 18.5] µmol · 100 g -1· min -1[P = 0.118]). Ephedrine significantly increased cerebral blood flow (difference [95% CI], 3.9 [0.7 to 7.0] ml · 100 g -1· min -1[P = 0.019]) and regional cerebral oxygen saturation (difference [95% CI], 4 [1 to 8]% [P = 0.024]) in the contralateral hemisphere compared to phenylephrine. The change in oxygen extraction fraction in both regions (peritumoral difference [95% CI], -0.6 [-14.7 to 13.6]% [P = 0.934]; contralateral hemisphere difference [95% CI], -0.1 [- 12.1 to 12.0]% [P = 0.989]) were comparable between groups. Conclusions: The cerebral metabolic rate of oxygen changes in peritumoral and normal contralateral regions were similar between ephedrine- and phenylephrine-treated patients. In the normal contralateral region, ephedrine was associated with an increase in cerebral blood flow and regional cerebral oxygen saturation compared with phenylephrine.

Original languageEnglish
JournalAnesthesiology
Volume133
Issue2
Pages (from-to)304-317
Number of pages14
ISSN0003-3022
DOIs
Publication statusPublished - Aug 2020

    Research areas

  • ANESTHESIA, CARDIAC-OUTPUT, CRANIOTOMY, ENERGY-METABOLISM, FRONTAL-LOBE OXYGENATION, INFUSION, NOREPINEPHRINE, PRESSURE, PROPOFOL, TRANSIT-TIME HETEROGENEITY, Ephedrine/pharmacology, Phenylephrine/pharmacology, Brain Neoplasms/diagnostic imaging, Prospective Studies, Anesthesia/trends, Humans, Middle Aged, Male, Cerebrovascular Circulation/drug effects, Adult, Female, Oxygen Consumption/drug effects, Double-Blind Method, Treatment Outcome, Vasoconstrictor Agents/pharmacology, Aged

See relations at Aarhus University Citationformats

ID: 189270445